Sedation and pain management in acute neurological disease

Seminars in Neurology

Volumn 28, Issue 5, 2008, Pages 611-630

  Mirski, Marek A ^a,c   Lewin III, John J ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Intensive care unit; Pharmacokinetics; Scales; Sedation; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CLONIDINE; DEXMEDETOMIDINE; DIAZEPAM; DROPERIDOL; FENTANYL; HALOPERIDOL; HYDROMORPHONE; KETAMINE; LORAZEPAM; MIDAZOLAM; MORPHINE; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST; NALOXONE; NARCOTIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORPETHIDINE; PARACETAMOL; PETHIDINE; PROPOFOL; REMIFENTANIL; SEDATIVE AGENT; STEROID;

ADRENAL SUPPRESSION; AGITATION; AKATHISIA; ANALGESIA; ANAPHYLAXIS; ANXIETY DISORDER; BRADYCARDIA; BRAIN FUNCTION; CLINICAL TRIAL; CONFUSION; CRITICALLY ILL PATIENT; DELIRIUM; DISEASE SEVERITY; DISSOCIATIVE DISORDER; DIZZINESS; DRUG DOSE TITRATION; DRUG MECHANISM; DYSPHORIA; EXTRAPYRAMIDAL SYMPTOM; FLUSHING; GASTRIC DYSMOTILITY; GASTROINTESTINAL MOTILITY DISORDER; HALLUCINATION; HEADACHE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPOTENSION; INJECTION SITE PAIN; INTENSIVE CARE UNIT; JAUNDICE; METABOLIC ACIDOSIS; MUSCLE HYPOTONIA; MUSCLE RIGIDITY; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NONHUMAN; ORTHOSTATIC HYPOTENSION; PAIN; PARKINSONISM; PERIORAL TREMOR; PHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; QT PROLONGATION; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; SEDATION; SEPSIS; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; TITRIMETRY; TORSADE DES POINTES; TRANQUILIZING ACTIVITY; TREATMENT INDICATION; URTICARIA; VERTIGO; XEROSTOMIA;

ACUTE DISEASE; ANALGESIA; ANALGESICS; ANTI-ANXIETY AGENTS; ANXIETY; BRAIN DISEASES; CONSCIOUS SEDATION; DELIRIUM; HUMANS; INTENSIVE CARE; PAIN;

EID: 58849102136     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0028-1105970     Document Type: Review

References (67)

1. Payen JF, Chanques G, Mantz J, et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007;106:687-695
2. Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA 2000;284:2317-2318
3. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000;342:1471-1477
4. Hogarth DK, Hall J. Management of sedation in mechanically ventilated patients. Curr Opin Crit Care 2004;10(1):40-46
5. Mirski MA, Muffelman B, Ulatowski JA, Hanley DF. Sedation for the critically ill neurologic patient. Crit Care Med 1995;23:2038-2053
6. Siffleet J, Young J, Nikoletti S, Shaw T. Patients' self-report of procedural pain in the intensive care unit. J Clin Nurs 2007;16:2142-2148
7. Li D, Puntillo K, Miaskowski C. A review of objective pain measures for use with critical care adult patients unable to self-report. J Pain 2008;9:2-10
8. Mateo OM, Krenzischek DA. A pilot study to assess the relationship between behavioral manifestations and self-report of pain in postanesthesia care unit patients. J Post Anesth Nurs 1992;7:15-21
9. Payen JF, Bru O, Bosson JL, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001;29:2258-2263
10. Gelinas C, Fillion L, Puntillo K, Viens C, Fortier M. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care 2006;15:420-427
11. Odhner M, Wegman D, Freeland N, Steinmetz A, Ingersoll G. Assessing pain control in nonverbal critically ill adults. Dimens Crit Care Nurs 2003;22:260-267
12. Puntillo KA, Miaskowski C, Kehrle K, Stannard D, Gleeson S, Nye P. Relationship between behavioral and physiological indicators of pain, critical care patients' self-reports of pain, and opioid administration. Crit Care Med 1997;25:1159-1166
13. Labus JS, Keefe FJ, Jensen MP. Self-reports of pain intensity and direct observations of pain behavior: When are they correlated? Pain 2003;102:109-124
14. Ely EW, Siegel MD, Inouye S. Delirium in the intensive care unit: an under-recognized syndrome of organ dysfunction. Semin Respir Crit Care Med 2001;22:115-126
15. Thomason JW, Shintani A, Peterson JF, et al. Intensive care delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care 2005;9:R375-R381
16. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ 1974;2:656-659
17. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999;27:1325-1329
18. Riker RR, Fraser GL, Simmons LE, Wilkins ML. Validating the Sedation-Agitation Scale with the Bispectral Index and Visual Analog Scale in adult ICU patients after cardiac surgery. Intensive Care Med 2001;27:853-858
19. Devlin JW, Boleski G, Mlynarek M, et al. Motor Activity Assessment Scale: a valid and reasonable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med 1999;27:1271-1275
20. Sessler CN, Gosnell MS, Grapp MJ, et al. The Richmond Agitation-Sedation Scale. Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002;166:1338-1344
21. De Jonghe B, Cook D, Griffith L, et al. Adaptation to the Intensive Care Environment (ATICE): development and validation of a new sedation assessment instrument. Crit Care Med 2003;31:2344-2354
22. Avripas MB, Smythe MA, Carr A, Begle RL, Johnson MH, Erb DR. Development of an intensive care unit bedside sedation scale. Ann Pharmacother 2001;35:262-263
23. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003;289:2983-2991
24. de Lemos J, Tweeddale M, Chittock D. Measuring quality of sedation in adult mechanically ventilated critically ill patients: the Vancouver Interaction and Calmness Scale. J Clin Epidemiol 2000;53:908-919
25. Weinert C, McFarland L. The state of intubated ICU patients. Development of a two-dimensional sedation rating scale for critically ill adults. Chest 2004;126:1883-1890
26. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-141
27. Park KS, Hur EJ, Han KW, Kil HY, Han TH. Bispectral index does not correlate with observer assessment of alertness and sedation scores during 0.5% bupivacaine epidural anesthesia with nitrous oxide sedation. Anesth Analg 2006;103:385-389
28. Sackey PV, Radell PJ, Granath F, Martling CR. Bispectral index as a predictor of sedation depth during isoflurane or midazolam sedation in ICU patients. Anaesth Intensive Care 2007;35:348-356
29. Tukenmez B, Memis D, Pamukcu Z. The addition of haloperidol, propofol, or midazolam to sufentanil for intravenous sedation in the intensive care unit using bispectral index. J Opioid Manag 2008;4:34-40
30. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001:569-619
31. Pan YX, Xu J, Bolan E, Moskowitz HS, Xu M, Pasternak GW. Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol Pharmacol 2005;68:866-875
32. Muellejans B, López A, Cross MH, Bonome C, Morrison L, Kirkham AJ. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial. Crit Care 2004;8:R1-R11
33. Rao TLK, Mummaneni N, El-Etr AA. Convulsions: an unusual response to intravenous fentanyl administration. Anesth Analg 1982;61:1020-1021
34. Murkin JM, Moldenhauer CC, Hug CC, et al. Absence of seizures during induction of anesthesia with high-dose fentanyl. Anesth Analg 1984;63:489-494
35. De Conno F, Caraceni A, Martini C, et al. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain 1991;47:337-339
36. Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987;66:723-730
37. Charney DS, Mihic SJ, Harris RA. Hypnotics and sedatives. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001:399-427
38. Greenblatt DJ, Divoll M, Abernathy DR, et al. Clinical pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 1983;8:233-252
39. Hoffman EJ, Warren EW. Flumazenil: a benzodiazepine antagonist. Clin Pharm 1993;12:641-656
40. Sanchez-Izquierdo-Riera JA, Caballero-Cubedo RE, Perez-Vela JL, Ambros-Checa A, Cantalapiedra-Santiago JA, Alted-Lopez E. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient. Anesth Analg 1998;86:1219-1224
41. Forster A, Juge O, Morel D. Effects of midazolam on cerebral hemodynamics and cerebral vasomotor responsiveness to carbon dioxide. J Cereb Blood Flow Metab 1983;3:246-249
42. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001;286:2703-2710
43. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001;27:859-864
44. Pandharipande P, Jackson J, Ely EW. Delirium: acute cognitive dysfunction in the critically ill. Curr Opin Crit Care 2005;11:360-368
45. Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001;57:1036-1042
46. Neale BW, Mesler EL, Young M, Rebuck JA, Weise WJ. Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations. Ann Pharmacother 2005;39:1732-1736
47. Barnes BJ, Gerst C, Terrell AR, Mullins ME. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy 2006;26:23-33
48. Dobrydnjov I, Axelsson K, Samarutel J, Holmstrom B. Postoperative pain relief following intrathecal bupivacaine combined with intrathecal or oral clonidine. Acta Anaesthesiol Scand 2002;46:806-814
49. Iskandar H, Guillaume E, Dixmerias F, et al. The enhancement of sensory blockade by clonidine selectively added to mepivacaine after midhumeral block. Anesth Analg 2001;93:771-775
50. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001;87:684-690
51. Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999;83:372-380
52. Tulen JH, van de Wetering BJ, Kruijk MP, et al. Cardiovascular, neuroendocrine, and sedative responses to four graded doses of clonidine in a placebo-controlled study. Biol Psychiatry 1992;32:485-500
53. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298:2644-2653
54. Szumita PM, Baroletti SA, Anger KE, Wechsler ME. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm 2007;64:37-44
55. Elbaradie S, El Mahalawy FH, Solyman AH. Dexmedetomidine vs. propofol for short-term sedation of postoperative mechanically ventilated patients. J Egypt Natl Canc Inst 2004;16:153-158
56. ter Minassian A, Beydon L, Decq P, Bonnet F. Changes in cerebral hemodynamics after a single dose of clonidine in severely head-injured patients. Anesth Analg 1997;84:127-132
57. Aryan HE, Box KW, Ibrahim D, Desiraju U, Ames CP. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj 2006;20:791-798
58. Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997;85:1136-1142
59. Riker R. The Precedex ICU Long Term Sedation Trial Results. Paper presented at: the Society of Critical Care Medicine 37th Critical Care Congress; February 2-6, 2008; Honolulu, HI
60. Baldessarini RJ, Tarazi FI. Drugs and the treatment of psychiatric disorders: psychosis and mania. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001:485-520
61. Misfeldt BB, Jorgensen PB, Spotoft H, Ronde F. The effects of droperidol and fentanyl on intracranial pressure and cerebral perfusion pressure in neurosurgical patients. Br J Anaesth 1976;48:963-968
62. Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J. Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 1994;79:983-986
63. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003;29:1417-1425
64. Alkire MT, Haier RJ. Correlating in vivo anaesthetic effects with ex vivo receptor density data supports a GABAergic mechanism of action for propofol, but not for isoflurane. Br J Anaesth 2001;86:618-626
65. Tsuchiya H. Structure-specific membrane-fluidizing effect of propofol. Clin Exp Pharmacol Physiol 2001;28:292-299
66. Greenblatt DJ. Intravenous anesthetic agents. Pharmacokinetic- pharmacodynamic relationships. Clin Pharmacokinet 1981;6:89-105
67. Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Crit Care Med 2000;28:3071-3074